SAM #NOI-CC-OLAO-26-008335

Intent to Sole Source: Belmont Rapid Infuser RI-2 with 5-Year Warranty for NIH Clinical Center PICU

This notice announces the NIH Clinical Center's intent to sole source the purchase of a Belmont Rapid Infuser RI-2 for its Pediatric Intensive Care Unit (PICU): - Agency: National Institutes of Health (NIH), Clinical Center - Product: Belmont Rapid Infuser RI-2, 120V, 1000 ML/MIN ENGLISH - Quantity: 1 unit - Includes a 5-year warranty - Sole Source Justification: - Only Belmont Rapid Infusers are currently used in the Clinical Center's PICU and other units - Device must match existing equipment for compatibility and standardization - Only OEM parts are acceptable - Scope of Procurement: - Firm-fixed price agreement - Includes all equipment, OEM parts, labor, travel, and onsite installation - Vendor must provide expertise for incident coordination and documentation - Competition: - Not open for full and open competition - Capability statements from other responsible sources will be considered - Commercial Opportunity: - Potential for other vendors to submit capability statements if they can meet all requirements - Key Requirements: - OEM parts only - Onsite installation and support - Expertise for adverse patient incident coordination

Description

This is a Notice of Intent, not a request for proposal.  The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Belmont Instrument Corporation.

Description:

The Clinical Center needs to buy a rapid fluid warmer to meet the needs of the soon to be established Pediatric Intensive Care Unit (PICU). The ICU currently uses 2 of the Belmont Rapid Infusers and the operating room also uses 2. These rapid fluid infusers are the only ones used for rapid fluid warming. This Firm-Fix Price agreement includes all equipment, parts, labor, travel, and onsite installation. This requirement encompasses only OEM parts. Vendor shall provide expertise to coordinate issues and documentation, in case of adverse patient incidents.

The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL.  All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-CC-OLAO-26-008335) by 12:00 PM eastern standard time on 08/03/2026 to: valerie.gregorio@nih.gov.

All responses received by the closing date of this synopsis will be considered by the Government.  A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.

View original listing